Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 25, 2020 11:50 ET | Source: Reports and Data

Breast Cancer Diagnostics Market to Reach USD 8,738.9 Million By 2027 | Reports And Data

New York, Nov. 25, 2020 (GLOBE NEWSWIRE) -- Growing awareness for early detection of breast cancer is one of the significant factors influencing the market growth. Market Size – USD 4,955.1 Million...
May 15, 2020 08:00 ET | Source: Biotheranostics, Inc.

Biotheranostics’ Breast Cancer Index® predicts benefit from two-and-a-half versus five years of extended endocrine therapy in HR+ breast cancer patients treated in the IDEAL trial

San Diego, CA, May 15, 2020 (GLOBE NEWSWIRE) -- Novel evidence demonstrating the ability of Breast Cancer Index to predict preferential endocrine response in distinct subgroups of HR+ early stage...
March 01, 2019 08:00 ET | Source: Bionano Genomics

Bionano Genomics Launches New Capabilities of the Saphyr System to Significantly Increase Its Cost Effectiveness, Speed and Ease of Use for Whole Human Genome Structural Variation Analysis and Digital Cytogenetics

SAN DIEGO, March 01, 2019 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr, a platform for ultra-sensitive and...
February 06, 2019 08:00 ET | Source: Bionano Genomics

Bionano Genomics’ Saphyr® System Used for Highly Accurate Detection of the Genetic Disorder FSHD as an Alternative to Southern Blot

SAN DIEGO, Feb. 06, 2019 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr, a platform for ultra-sensitive and...
January 14, 2019 08:00 ET | Source: Bionano Genomics

Global Adoption of Bionano Genomics’ Saphyr® System Accelerating for Clinical Genomics Applications

SAN DIEGO, Jan. 14, 2019 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets the Saphyr system, which enables ultra-sensitive...
October 19, 2018 20:51 ET | Source: Bionano Genomics; GrandOmics Biosciences

UPDATE – GrandOmics Biosciences Offers Genetic Test Using the Saphyr System for Molecular Diagnosis of Facioscapulohumeral Muscular Dystrophy (FSHD) in China

SAN DIEGO, Oct. 19, 2018 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr, a platform for ultra-sensitive and...
October 17, 2018 11:00 ET | Source: Bionano Genomics

Bionano and Genoox Launch Integrated Platform for Identification of Structural Variants in DNA

SAN DIEGO, Oct. 17, 2018 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr, a platform for ultra-sensitive and...
November 01, 2017 08:00 ET | Source: Bionano Genomics

Bionano Genome Mapping Found to Be Superior to Existing Clinical Tests for the Identification of Pathogenic Structural Variants in Duchenne Muscular Dystrophy

SAN DIEGO, Nov. 01, 2017 (GLOBE NEWSWIRE) -- In a publication in Genome Medicine, a team of researchers from Children’s National Health Center (CNHC) and the University of California, Los Angeles...
October 19, 2017 14:00 ET | Source: Bionano Genomics

Beijing Grandomics Announces Intent to Use the Saphyr System for Molecular Diagnosis of Facioscapulohumeral Muscular Dystrophy (FSHD) in China

BEIJING and ORLANDO, Fla., Oct. 19, 2017 (GLOBE NEWSWIRE) -- At the 2017 annual meeting of the American Society of Human Genetics in Orlando, Depeng Wang, the Chief Executive Officer of Beijing...
June 28, 2017 08:00 ET | Source: BioNano Genomics; Genoptix, Inc.

Genoptix and Bionano Genomics Announce Strategic Alliance

SAN DIEGO and CARLSBAD, Calif., June 28, 2017 (GLOBE NEWSWIRE) -- Genoptix, Inc., a leading oncology diagnostics and informatics company, and Bionano Genomics®, Inc., a company focused on genome...

Next Page keyboard_arrow_right